Page 8 - Shimadzu Journal vol.9 Issue2
P. 8

INSIGHT from CUSTOMER







                   Interview 2  Interview with Dr. Shivam Mukherjee
                 “It is excellent and


                    extremely beneficial

                    in support of our research


                    and development process.”





                    We interviewed Dr. Shivam Mukherjee from Intas Biopharma Ltd. in India, a leading
                    biosimilar product manufacturers in Asia having its own biopharmaceutical opera-
                    tions with a R&D facility and an EU-GMP certified bio-pharmaceutical manufacturing
                    facility.  Shimadzu  have  been  supporting  the  research  and  development  activities
                    undergoing at Intas.

                       Hello Dr. Mukherjee, thank you very much       focusses on characterization of the developing mole-
                       for spending some time for this interview.     cule using a variety of analytical techniques.
                       At first, could you brief about your
                       organization, type of research carried out,    Could you describe the importance of
                       product line etc?                              cultivation condition such as media,
                                                                      feed in mAb production and how it will
                       At Intas Biopharma unit, we focus on developing re-  impact on final mAb drug quality?
                       combinant DNA and plasma derived products. We are
                       focused on developing biosimilars of therapeutic mono-  Media and feed component are important as these
                       clonal antibodies with the goal of ‘Biosimilar for Billions’.  has direct impact on cell growth. Cell culture media pro-
                                                                      vides a medium for the cell to grow and also a source
                       Could you outline the research activities      for cell growth and production while feed improves the
                       carried out in your department?                culture duration and productivity. In this context, spent
                                                                      media analysis from cell culture can identify the de-
                       The R&D department at Intas Biopharma unit consists   pleted components, which can then be added back
                       of  several functions starting from developing clones   to the  media either through  front  loading in  basal
                       to, screening of media followed by process design   media or feed enhancement at different culture dura-
                       and optimization of product. At all stages the  process   tion timepoints.
                       teams are supported by a strong analytical team which

                       Intas team
                       From L to R: Shivam Mukherjee, Sreekant Panicker, Nitin Kishor, Salma Bano, Babu Ponnusamy, Nilesh Aghera, Shrinivas Ambekar, Harshit Srivastava, Chetna Kirad.























                                                                                                Shimadzu Journal  vol.9  Issue2 41
   3   4   5   6   7   8   9   10   11   12   13